Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
650
-
Total 13F shares, excl. options
-
96,700,199
-
Shares change
-
-2,409,508
-
Total reported value, excl. options
-
$23,835,730,320
-
Value change
-
-$548,687,648
-
Put/Call ratio
-
76.29%
-
Number of buys
-
267
-
Number of sells
-
-312
-
Price
-
$246.52
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2021
737 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2021.
RESMED INC - Common Stock (RMD) has 650 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96,700,199 shares
of 146,467,184 outstanding shares and own 66.02% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,415,804 shares), BlackRock Inc. (12,659,856 shares), WCM INVESTMENT MANAGEMENT, LLC (9,106,110 shares), STATE STREET CORP (6,199,556 shares), FMR LLC (4,209,644 shares), Capital World Investors (3,673,857 shares), BAILLIE GIFFORD & CO (3,240,089 shares), GEODE CAPITAL MANAGEMENT, LLC (2,865,328 shares), NORTHERN TRUST CORP (2,161,157 shares), and Invesco Ltd. (1,787,191 shares).
This table shows the top 650 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.